What is it about?
Methotrexate therapy is central to the treatment of patients with rheumatoid arthritis. We present a novel laboratory method capable of measuring methotrexate to very low concentrations in patients' blood samples. This method has the potential to be the first used in monitoring adherence to methotrexate treatment in rheumatoid arthritis.
Featured Image
Read the Original
This page is a summary of: A sensitive LC-MS/MS methotrexate assay capable of assessing adherence to methotrexate therapy in rheumatoid arthritis, Clinical Chemistry and Laboratory Medicine (CCLM), August 2023, De Gruyter,
DOI: 10.1515/cclm-2023-0350.
You can read the full text:
Contributors
Be the first to contribute to this page